CODX
$1.32
Revenue | $2.46Mn |
Net Profits | $-5.98Mn |
Net Profit Margins | -243.47% |
Co-diagnostics Inc’s revenue fell -51.77% since last year same period to $2.46Mn in the Q3 2023. On a quarterly growth basis, Co-diagnostics Inc has generated 1142.18% jump in its revenue since last 3-months.
Co-diagnostics Inc’s net profit fell -339.52% since last year same period to $-5.98Mn in the Q3 2023. On a quarterly growth basis, Co-diagnostics Inc has generated 32.93% jump in its net profits since last 3-months.
Co-diagnostics Inc’s net profit margin fell -811.29% since last year same period to -243.47% in the Q3 2023. On a quarterly growth basis, Co-diagnostics Inc has generated 94.6% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.24 |
EPS Estimate Current Year | -0.24 |
Co-diagnostics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.24 - a -20% fall from last quarter’s estimates.
Co-diagnostics Inc’s earning per share (EPS) estimates for the current year stand at -0.24.
Earning Per Share (EPS) | -0.2 |
Co-diagnostics Inc’s earning per share (EPS) fell -400% since last year same period to -0.2 in the Q3 2023. This indicates that the Co-diagnostics Inc has generated -400% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-11-09 | -0.29 | -0.2 | 31.03% |
2023-08-10 | -0.24 | -0.31 | -29.17% |
2023-05-11 | -0.22 | -0.2 | 9.09% |